News
Green light for cancer drugs developed by AI specialist Owkin
AI biotech company Owkin has announced that two first-in-class rapid, affordable AI-based diagnostic solutions – designed to improve outcomes for patients with breast cancer and colorectal cancer – have been approved for use in Europe.